These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 12057642

  • 21. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
    Walczyński K, Zuiderveld OP, Timmerman H.
    Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G, Comini M, Rivara M, Rivara S, Bordi F, Plazzi PV, Flammini L, Saccani F, Bertoni S, Ballabeni V, Barocelli E, Mor M.
    Bioorg Med Chem; 2008 Dec 01; 16(23):9911-24. PubMed ID: 18976927
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists.
    Dandu RR, Lyons JA, Raddatz R, Huang Z, Aimone LD, Hudkins RL.
    Bioorg Med Chem Lett; 2012 Mar 15; 22(6):2151-3. PubMed ID: 22365751
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives.
    Apelt J, Grassmann S, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    Pharmazie; 2005 Feb 15; 60(2):97-106. PubMed ID: 15739896
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. General construction pattern of histamine H3-receptor antagonists: change of a paradigm.
    Stark H, Ligneau X, Arrang JM, Schwartz JC, Schunack W.
    Bioorg Med Chem Lett; 1998 Aug 04; 8(15):2011-6. PubMed ID: 9873477
    [Abstract] [Full Text] [Related]

  • 32. Non-Imidazole Histamine H₃ Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines.
    Guryn R, Staszewski M, Stasiak A, McNaught Flores D, Fogel WA, Leurs R, Walczyński K.
    Molecules; 2018 Feb 03; 23(2):. PubMed ID: 29401659
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.
    Reidemeister S, Stark H, Ligneau X, Ganellin CR, Schwartz JC, Schunack W.
    Pharmazie; 2000 Feb 03; 55(2):83-6. PubMed ID: 10723763
    [Abstract] [Full Text] [Related]

  • 35. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
    Plazzi PV, Mor M, Bordi F, Silva C, Rivara S, Caretta A, Ballabeni V, Impicciatore M, Vitali T.
    Farmaco; 1997 May 03; 52(5):295-302. PubMed ID: 9274000
    [Abstract] [Full Text] [Related]

  • 36. Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.
    Kieć-Kononowicz K, Wiecek M, Sasse A, Ligneau X, Elz S, Ganellin CR, Schwartz JC, Stark H, Schunack W.
    Pharmazie; 2000 May 03; 55(5):349-55. PubMed ID: 11828613
    [Abstract] [Full Text] [Related]

  • 37. Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.
    Stark H, Hüls A, Ligneau X, Arrang JM, Schwartz JC, Schunack W.
    Pharmazie; 1997 Jul 03; 52(7):495-500. PubMed ID: 9266588
    [Abstract] [Full Text] [Related]

  • 38. 4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H₃ Receptor Antagonist: Further Structure⁻Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation.
    Olszewska B, Stasiak A, McNaught Flores D, Fogel WA, Leurs R, Walczyński K.
    Int J Mol Sci; 2018 Apr 19; 19(4):. PubMed ID: 29671795
    [Abstract] [Full Text] [Related]

  • 39. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B, Elz S, Pertz HH, Stark H, Schunack W.
    Inflamm Res; 2004 Aug 19; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [Abstract] [Full Text] [Related]

  • 40. 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.
    Dvorak CA, Apodaca R, Barbier AJ, Berridge CW, Wilson SJ, Boggs JD, Xiao W, Lovenberg TW, Carruthers NI.
    J Med Chem; 2005 Mar 24; 48(6):2229-38. PubMed ID: 15771465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.